Navigation Links
Use of psychedelic drugs remains prevalent in the United States
Date:4/23/2013

In their article "Over 30 million psychedelic users in the United States", Teri S Krebs and Pl-rjan Johansen from the Department of Neuroscience at Norwegian University of Science and Technology, use data from a randomly-selected sample of over 57,000 individuals surveyed for the 2010 National Survey on Drug Use and Health (NSDUH), to estimate lifetime prevalence of psychedelic use. The authors estimate that approximately 32 million people have used LSD (lysergic acid diethylamide), psilocybin ("magic mushrooms"), or mescaline (peyote and other cacti) in their lifetime. This includes 17% of US adults aged 21 to 64 years. The highest rate of psychedelic use was in the 30 to 34 age group, with an overall rate of 20%, or 26% of males and 15% of females.

"Lifetime use of psychedelics doesn't seem to have changed much since the sixties - psychedelics continue to be widely used in the US and worldwide," the researchers say.

The mechanisms of action, subjective effects, and risk profile of the classical serotonergic psychedelics, distinguish them from other drugs, the authors wrote.

"Psychedelics are different from other drugs, in that they are not known to be physically harmful or cause addiction or compulsive use. Experts agree that psychedelics are less harmful than alcohol and most other recreational drugs, although psychedelics can elicit anxiety and confusion during the drug effects", the researchers say.

The authors estimated that older adults were more likely to have used LSD and mescaline, whereas younger adults were more likely to have used "magic mushrooms". In addition, the authors note that use of "magic mushrooms" is known to have increased since the 1970s.

"People often report mystical experiences as a major reason for using psychedelics. Archaeological evidence shows that psychedelic plants have been used in the Americas for over 5000 years, and currently around 300,000 people in the US enjoy a recognized religious freedom right to use psychedelics." Krebs and Johansen said.


'/>"/>

Contact: Eleanor Howell
press@f1000.com
44-020-763-19129
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Related medicine news :

1. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
2. HIV Drugs May Help Protect Young Patients Hearts: Study
3. Is your migraine preventive treatment balanced between drugs benefits and harms?
4. Drugs Can Cut Breast Cancer Risk for Some, Task Force Finds
5. Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
6. No evidence drugs, vitamins, supplements help prevent cognitive decline in healthy older adults
7. Interactions between drugs can also be measured at lowest doses
8. GUMBOS technology promises new drugs, electronic devices
9. TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
10. FDA and Legislators Introduce Bill Aimed at Reclassifying and Restricting Hydrocodone Drugs
11. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... MA (PRWEB) , ... April 24, 2017 , ... ... cardiovascular health of individuals with HIV because it is not known to have ... may have favorable effects to both lower cholesterol levels and dampen inflammation in ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... 2017 , ... Anaconda BioMed, a pre-clinical stage medical device ... of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical to ... regulatory and clinical phases. , "This is another important step for Anaconda Biomed ...
(Date:4/22/2017)... North Carolina (PRWEB) , ... April 22, 2017 , ... ... in the United States estimated to be $394.9 billion. The consequences of rapid ... (and inevitably demolishes) the limits of technology, it is every business and individual’s job ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., ... case series to be presented at the 2017 National ... begins today and continues through April 22. Physicians will ... , used to assess risk for acute kidney injury ... heart failure (ADHF). Elevated levels of ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext ... of collaboration started in 2016, in which Socionext ... Brain SOINN". The companies achieved initial results in ... solution by Artificial Brain SOINN. The results will ... Big Sight, April 19-21, at booths 4505 & ...
Breaking Medicine Technology: